[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Romiplostim Market Growth (Status and Outlook) 2023-2029

March 2023 | 63 pages | ID: G4BA7B0620CEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Romiplostim (rINN, USAN) is a fusion protein analog of thrombopoietin, a hormone that regulates platelet production.

LPI (LP Information)' newest research report, the “Romiplostim Industry Forecast” looks at past sales and reviews total world Romiplostim sales in 2022, providing a comprehensive analysis by region and market sector of projected Romiplostim sales for 2023 through 2029. With Romiplostim sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Romiplostim industry.

This Insight Report provides a comprehensive analysis of the global Romiplostim landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Romiplostim portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Romiplostim market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Romiplostim and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Romiplostim.

The global Romiplostim market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Romiplostim is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Romiplostim is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Romiplostim is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Romiplostim players cover AMGEN. etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Romiplostim market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
  • 250 ?g/0.5 mL
  • 500 ?g/1 mL
Segmentation by application
  • Adults
  • Pediatric patients
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • AMGEN
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Romiplostim Market Size 2018-2029
  2.1.2 Romiplostim Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Romiplostim Segment by Type
  2.2.1 250 ?g/0.5 mL
  2.2.2 500 ?g/1 mL
2.3 Romiplostim Market Size by Type
  2.3.1 Romiplostim Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Romiplostim Market Size Market Share by Type (2018-2023)
2.4 Romiplostim Segment by Application
  2.4.1 Adults
  2.4.2 Pediatric patients
2.5 Romiplostim Market Size by Application
  2.5.1 Romiplostim Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Romiplostim Market Size Market Share by Application (2018-2023)

3 ROMIPLOSTIM MARKET SIZE BY PLAYER

3.1 Romiplostim Market Size Market Share by Players
  3.1.1 Global Romiplostim Revenue by Players (2018-2023)
  3.1.2 Global Romiplostim Revenue Market Share by Players (2018-2023)
3.2 Global Romiplostim Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ROMIPLOSTIM BY REGIONS

4.1 Romiplostim Market Size by Regions (2018-2023)
4.2 Americas Romiplostim Market Size Growth (2018-2023)
4.3 APAC Romiplostim Market Size Growth (2018-2023)
4.4 Europe Romiplostim Market Size Growth (2018-2023)
4.5 Middle East & Africa Romiplostim Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Romiplostim Market Size by Country (2018-2023)
5.2 Americas Romiplostim Market Size by Type (2018-2023)
5.3 Americas Romiplostim Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Romiplostim Market Size by Region (2018-2023)
6.2 APAC Romiplostim Market Size by Type (2018-2023)
6.3 APAC Romiplostim Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Romiplostim by Country (2018-2023)
7.2 Europe Romiplostim Market Size by Type (2018-2023)
7.3 Europe Romiplostim Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Romiplostim by Region (2018-2023)
8.2 Middle East & Africa Romiplostim Market Size by Type (2018-2023)
8.3 Middle East & Africa Romiplostim Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ROMIPLOSTIM MARKET FORECAST

10.1 Global Romiplostim Forecast by Regions (2024-2029)
  10.1.1 Global Romiplostim Forecast by Regions (2024-2029)
  10.1.2 Americas Romiplostim Forecast
  10.1.3 APAC Romiplostim Forecast
  10.1.4 Europe Romiplostim Forecast
  10.1.5 Middle East & Africa Romiplostim Forecast
10.2 Americas Romiplostim Forecast by Country (2024-2029)
  10.2.1 United States Romiplostim Market Forecast
  10.2.2 Canada Romiplostim Market Forecast
  10.2.3 Mexico Romiplostim Market Forecast
  10.2.4 Brazil Romiplostim Market Forecast
10.3 APAC Romiplostim Forecast by Region (2024-2029)
  10.3.1 China Romiplostim Market Forecast
  10.3.2 Japan Romiplostim Market Forecast
  10.3.3 Korea Romiplostim Market Forecast
  10.3.4 Southeast Asia Romiplostim Market Forecast
  10.3.5 India Romiplostim Market Forecast
  10.3.6 Australia Romiplostim Market Forecast
10.4 Europe Romiplostim Forecast by Country (2024-2029)
  10.4.1 Germany Romiplostim Market Forecast
  10.4.2 France Romiplostim Market Forecast
  10.4.3 UK Romiplostim Market Forecast
  10.4.4 Italy Romiplostim Market Forecast
  10.4.5 Russia Romiplostim Market Forecast
10.5 Middle East & Africa Romiplostim Forecast by Region (2024-2029)
  10.5.1 Egypt Romiplostim Market Forecast
  10.5.2 South Africa Romiplostim Market Forecast
  10.5.3 Israel Romiplostim Market Forecast
  10.5.4 Turkey Romiplostim Market Forecast
  10.5.5 GCC Countries Romiplostim Market Forecast
10.6 Global Romiplostim Forecast by Type (2024-2029)
10.7 Global Romiplostim Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 AMGEN
  11.1.1 AMGEN Company Information
  11.1.2 AMGEN Romiplostim Product Offered
  11.1.3 AMGEN Romiplostim Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 AMGEN Main Business Overview
  11.1.5 AMGEN Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Romiplostim Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of 250 ?g/0.5 mL
Table 3. Major Players of 500 ?g/1 mL
Table 4. Romiplostim Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Romiplostim Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Romiplostim Market Size Market Share by Type (2018-2023)
Table 7. Romiplostim Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Romiplostim Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Romiplostim Market Size Market Share by Application (2018-2023)
Table 10. Global Romiplostim Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Romiplostim Revenue Market Share by Player (2018-2023)
Table 12. Romiplostim Key Players Head office and Products Offered
Table 13. Romiplostim Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Romiplostim Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Romiplostim Market Size Market Share by Regions (2018-2023)
Table 18. Global Romiplostim Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Romiplostim Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Romiplostim Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Romiplostim Market Size Market Share by Country (2018-2023)
Table 22. Americas Romiplostim Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Romiplostim Market Size Market Share by Type (2018-2023)
Table 24. Americas Romiplostim Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Romiplostim Market Size Market Share by Application (2018-2023)
Table 26. APAC Romiplostim Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Romiplostim Market Size Market Share by Region (2018-2023)
Table 28. APAC Romiplostim Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Romiplostim Market Size Market Share by Type (2018-2023)
Table 30. APAC Romiplostim Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Romiplostim Market Size Market Share by Application (2018-2023)
Table 32. Europe Romiplostim Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Romiplostim Market Size Market Share by Country (2018-2023)
Table 34. Europe Romiplostim Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Romiplostim Market Size Market Share by Type (2018-2023)
Table 36. Europe Romiplostim Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Romiplostim Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Romiplostim Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Romiplostim Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Romiplostim Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Romiplostim Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Romiplostim Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Romiplostim Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Romiplostim
Table 45. Key Market Challenges & Risks of Romiplostim
Table 46. Key Industry Trends of Romiplostim
Table 47. Global Romiplostim Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Romiplostim Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Romiplostim Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Romiplostim Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. AMGEN Details, Company Type, Romiplostim Area Served and Its Competitors
Table 52. AMGEN Romiplostim Product Offered
Table 53. AMGEN Romiplostim Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. AMGEN Main Business
Table 55. AMGEN Latest Developments

LIST OF FIGURES

Figure 1. Romiplostim Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Romiplostim Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Romiplostim Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Romiplostim Sales Market Share by Country/Region (2022)
Figure 8. Romiplostim Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Romiplostim Market Size Market Share by Type in 2022
Figure 10. Romiplostim in Adults
Figure 11. Global Romiplostim Market: Adults (2018-2023) & ($ Millions)
Figure 12. Romiplostim in Pediatric patients
Figure 13. Global Romiplostim Market: Pediatric patients (2018-2023) & ($ Millions)
Figure 14. Global Romiplostim Market Size Market Share by Application in 2022
Figure 15. Global Romiplostim Revenue Market Share by Player in 2022
Figure 16. Global Romiplostim Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Romiplostim Market Size 2018-2023 ($ Millions)
Figure 18. APAC Romiplostim Market Size 2018-2023 ($ Millions)
Figure 19. Europe Romiplostim Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Romiplostim Market Size 2018-2023 ($ Millions)
Figure 21. Americas Romiplostim Value Market Share by Country in 2022
Figure 22. United States Romiplostim Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Romiplostim Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Romiplostim Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Romiplostim Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Romiplostim Market Size Market Share by Region in 2022
Figure 27. APAC Romiplostim Market Size Market Share by Type in 2022
Figure 28. APAC Romiplostim Market Size Market Share by Application in 2022
Figure 29. China Romiplostim Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Romiplostim Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Romiplostim Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Romiplostim Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Romiplostim Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Romiplostim Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Romiplostim Market Size Market Share by Country in 2022
Figure 36. Europe Romiplostim Market Size Market Share by Type (2018-2023)
Figure 37. Europe Romiplostim Market Size Market Share by Application (2018-2023)
Figure 38. Germany Romiplostim Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Romiplostim Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Romiplostim Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Romiplostim Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Romiplostim Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Romiplostim Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Romiplostim Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Romiplostim Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Romiplostim Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Romiplostim Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Romiplostim Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Romiplostim Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Romiplostim Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Romiplostim Market Size 2024-2029 ($ Millions)
Figure 52. APAC Romiplostim Market Size 2024-2029 ($ Millions)
Figure 53. Europe Romiplostim Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Romiplostim Market Size 2024-2029 ($ Millions)
Figure 55. United States Romiplostim Market Size 2024-2029 ($ Millions)
Figure 56. Canada Romiplostim Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Romiplostim Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Romiplostim Market Size 2024-2029 ($ Millions)
Figure 59. China Romiplostim Market Size 2024-2029 ($ Millions)
Figure 60. Japan Romiplostim Market Size 2024-2029 ($ Millions)
Figure 61. Korea Romiplostim Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Romiplostim Market Size 2024-2029 ($ Millions)
Figure 63. India Romiplostim Market Size 2024-2029 ($ Millions)
Figure 64. Australia Romiplostim Market Size 2024-2029 ($ Millions)
Figure 65. Germany Romiplostim Market Size 2024-2029 ($ Millions)
Figure 66. France Romiplostim Market Size 2024-2029 ($ Millions)
Figure 67. UK Romiplostim Market Size 2024-2029 ($ Millions)
Figure 68. Italy Romiplostim Market Size 2024-2029 ($ Millions)
Figure 69. Russia Romiplostim Market Size 2024-2029 ($ Millions)
Figure 70. Spain Romiplostim Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Romiplostim Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Romiplostim Market Size 2024-2029 ($ Millions)
Figure 73. Israel Romiplostim Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Romiplostim Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Romiplostim Market Size 2024-2029 ($ Millions)
Figure 76. Global Romiplostim Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Romiplostim Market Size Market Share Forecast by Application (2024-2029)


More Publications